Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Martin, Mary I
13157  Ergebnisse:
Personensuche X
?
1

Connecting families: a qualitative study examining the expe..:

Martin, Mary I. ; Mauer-Vakil, Dane ; Borkhoff, Cornelia M...
BMC Public Health.  24 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
2

Self‐withdrawal from scheduled bariatric surgery: Qualitati..:

Martin, Mary I. ; Ha, Vanessa ; Fasola, Laurie..
Clinical Obesity.  13 (2022)  1 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
3

The role of the practice facilitators in Ontario primary he..:

Kotecha, Jyoti ; Han, Han ; Green, Michael...
BMC Family Practice.  16 (2015)  1 - p. , 2015
Link: https://doi.org/10.1186/..
 
?
4

Implementation of Health Links coordinated care plans for a..:

Martin, Mary I ; Grier, Elizabeth ; Bobbette, Nicole...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501720/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
5

The role of the practice facilitators in Ontario primary he..:

Kotecha, Jyoti ; Han, Han ; Green, Michael...
http://www.biomedcentral.com/1471-2296/16/93.  , 2015
Link: http://www.biomedcentral..
 
?
6

Interim Results of a Phase I/II Trial of Intermediate-Dose ..:

McCurdy, Shannon R. ; Hyder, Mustafa A. ; Sabina, Ruby...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S2-S3 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Post-Transplant Frailty Phenotype Predicts Survival:

Hadjis, Ashley D. ; White, Griffin W. ; Gill, Saar I....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S407-S408 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Interim Results of a Phase I/II Study of Intermediate-Dose ..:

Hyder, Mustafa A. ; McCurdy, Shannon R. ; Sabina, Ruby...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S284-S285 , 2024
Link: https://doi.org/10.1016/..
 
?
9

One versus two sets of busulfan therapeutic drug monitoring..:

Chippendale, Lindsey ; Freyer, Craig W ; Carulli, Alison...
Journal of Oncology Pharmacy Practice.  30 (2023)  5 - p. 802-810 , 2023
Link: https://doi.org/10.1177/..
 
?
10

Real‐world effectiveness of intensive chemotherapy with 7&3..:

Matthews, Andrew H. ; Perl, Alexander E. ; Luger, Selina M....
American Journal of Hematology.  98 (2023)  8 - p. 1254-1264 , 2023
Link: https://doi.org/10.1002/..
 
?
11

Clofarabine and Busulfan Myeloablative Conditioning in Allo..:

Connor, Matthew P. ; Loren, Alison W. ; Hexner, Elizabeth O....
Transplantation and Cellular Therapy.  29 (2023)  2 - p. 113-118 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Salvage therapy with basiliximab and etanercept for severe ..:

Freyer, Craig W. ; Gier, Shannon ; Carulli, Alison...
American Journal of Hematology.  97 (2022)  7 - p. , 2022
Link: https://doi.org/10.1002/..
 
?
13

Real-world effectiveness of CPX-351 vs venetoclax and azaci..:

Matthews, Andrew H. ; Perl, Alexander E. ; Luger, Selina M....
Blood Advances.  6 (2022)  13 - p. 3997-4005 , 2022
Link: https://doi.org/10.1182/..
 
?
14

Day 4 vs. day 12 G-CSF administration following reduced int..:

Hatch, Rachel V. ; Freyer, Craig W. ; Carulli, Alison...
Journal of Oncology Pharmacy Practice.  28 (2022)  4 - p. 892-897 , 2022
Link: https://doi.org/10.1177/..
 
?
15

Low-Dose Total Body Irradiation Added to Fludarabine and Bu..:

Freyer, Craig W. ; Babushok, Daria V. ; Frey, Noelle V....
Transplantation and Cellular Therapy.  28 (2022)  9 - p. 590-596 , 2022
Link: https://doi.org/10.1016/..
 
1-15